Prawo i regulacje · 28/06/2021

AMRI Rensselaer, Inc. Seeks Registration as Controlled Substance Importer

AMRI Rensselaer, Inc. has submitted an application to the U.S. government to become a registered importer of controlled substances, a move that could impact the pharmaceutical industry.